SAN DIEGO, Sept. 12, 2016 /PRNewswire/ --
Shareholder rights law firm Johnson & Weaver, LLP has launched an investigation into whether the board members of Raptor Pharmaceutical Corp. (NASDAQ: RPTP) breached their fiduciary duties in connection with the proposed sale of the Company to Horizon Pharma Plc.
Raptor is a biopharmaceutical company that focuses on developing and commercializing transformative treatments for people affected by rare and debilitating diseases.
On September 12, 2016, Raptor announced it had signed a definitive merger agreement with Horizon. Under the terms of the agreement, Horizon will pay $9.00 per share in cash for each share of Raptor common stock.
The investigation concerns whether the Raptor board failed to satisfy their duties to the Company shareholders, including whether the board adequately pursued alternatives to the acquisition and whether the board obtained the best price possible for Raptor shares of common stock. Nationally recognized Johnson & Weaver is investigating whether the proposed deal price represents adequate consideration. The deal may undervalue the Company resulting in a loss for many long term shareholders. For example, in July 2015, Raptor traded at over $15.00.
If you are a shareholder of Raptor and believe the proposed buyout price is too low and you're interested in learning more about the investigation or your legal rights and remedies, please contact lead analyst Jim Baker (email@example.com) at 619-814-4471.
About Johnson & Weaver, LLP:
Johnson & Weaver, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonandweaver.com. Attorney advertising. Past results do not guarantee future outcomes.
Johnson & Weaver, LLP
Jim Baker, 619-814-4471
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/raptor-rptp-alert-johnson--weaver-llp-launches-an-investigation-into-the-fairness-of-price-and-process-in-proposed-sale-of-raptor-pharmaceutical-corp-are-shareholders-getting-a-fair-price-300326124.html
SOURCE Johnson & Weaver, LLP